share_log

China Resources Medical Holdings Company Limited's (HKG:1515) Largest Shareholders Are Individual Investors Who Were Rewarded as Market Cap Surged HK$428m Last Week

China Resources Medical Holdings Company Limited's (HKG:1515) Largest Shareholders Are Individual Investors Who Were Rewarded as Market Cap Surged HK$428m Last Week

中國資源醫療控股有限公司(HKG:1515)的最大股東是個人投資者,在上週市值飆升了4.28億港元,受到獎勵。
Simply Wall St ·  09/26 16:22

Key Insights

主要見解

  • China Resources Medical Holdings' significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public
  • The top 6 shareholders own 51% of the company
  • Institutions own 21% of China Resources Medical Holdings
  • 中國資源醫療控股的重要個人投資者持股情況表明,關鍵決策受到更大公衆股東的影響
  • 前6大股東擁有公司51%的股份。
  • 機構擁有中國資源醫療控股21%的股權

Every investor in China Resources Medical Holdings Company Limited (HKG:1515) should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are individual investors with 43% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

每位投資中國資源醫療控股有限公司(HKG:1515)的投資者都應該注意最強大的股東群體。持有公司43%股權的個人投資者群體佔據着最大的股份。換句話說,該群體將從他們對公司的投資中獲得最多(或損失最多)的回報。

Clearly, individual investors benefitted the most after the company's market cap rose by HK$428m last week.

顯然,個人投資者在上週公司市值增加了42800萬港元后受益最多。

Let's delve deeper into each type of owner of China Resources Medical Holdings, beginning with the chart below.

讓我們深入研究中國資源醫療控股的每種所有者類型,從下面的圖表開始。

big
SEHK:1515 Ownership Breakdown September 26th 2024
SEHK:1515所有權拆分2024年9月26日

What Does The Institutional Ownership Tell Us About China Resources Medical Holdings?

機構持股告訴我們有關中國資源醫療控股的什麼?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

機構通常在向自己的投資者報告時會針對一個基準進行衡量,因此一旦某隻股票被納入主要指數,他們通常會更加熱衷於該股票。我們預計大多數公司都會有一些機構在登記簿上,尤其是那些正在增長的公司。

As you can see, institutional investors have a fair amount of stake in China Resources Medical Holdings. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of China Resources Medical Holdings, (below). Of course, keep in mind that there are other factors to consider, too.

正如您所看到的,機構投資者在中國資源醫療控股中持有相當大比例的股份。 這表明在專業投資者中有一定的可信度。 但我們不能僅依靠這個事實,因爲機構有時也會做出糟糕的投資,就像每個人一樣。 如果兩家大型機構投資者同時試圖拋售某隻股票,很可能會看到股價大幅下跌。 因此,值得檢查中國資源醫療控股的過往盈利軌跡(如下)。 當然,也要記住還有其他因素需要考慮。

big
SEHK:1515 Earnings and Revenue Growth September 26th 2024
SEHK:1515 2024年9月26日的收益和營業收入增長

Hedge funds don't have many shares in China Resources Medical Holdings. Our data shows that China Resources Company Limited is the largest shareholder with 37% of shares outstanding. For context, the second largest shareholder holds about 4.9% of the shares outstanding, followed by an ownership of 3.4% by the third-largest shareholder.

對於華潤醫療控股,對沖基金持有的股份不多。我們的數據顯示,中國華潤有限公司是最大的股東,持有37%的流通股份。第二大股東持有約4.9%的流通股份,而第三大股東持有3.4%的流通股份。

We did some more digging and found that 6 of the top shareholders account for roughly 51% of the register, implying that along with larger shareholders, there are a few smaller shareholders, thereby balancing out each others interests somewhat.

我們進行了更深入的研究,發現前6名股東大約佔有51%的持股比例,意味着除了大股東以外,還有一些小股東,因此在一定程度上平衡了各自的利益。

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.

儘管研究公司機構所有權數據是有意義的,但了解分析師的情緒也很有意義,以了解市場的走向。因爲有很多分析師正在跟蹤這個股票,所以看看他們的預測可能是值得的。

Insider Ownership Of China Resources Medical Holdings

華潤醫療控股的內部所有權

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

內部人員的定義在不同國家可能會稍有不同,但董事會成員始終算入其中。公司管理負責經營業務,但即使首席執行官是董事會成員,他或她也必須對董事會負責。

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

我通常認爲內部人士持股是一件好事。但是,在某些情況下,它會使其他股東更難以對董事會的決定進行問責。

Our data suggests that insiders own under 1% of China Resources Medical Holdings Company Limited in their own names. However, it's possible that insiders might have an indirect interest through a more complex structure. It has a market capitalization of just HK$4.9b, and the board has only HK$1.8m worth of shares in their own names. Many investors in smaller companies prefer to see the board more heavily invested. You can click here to see if those insiders have been buying or selling.

我們的數據表明,內部人士以自己的名義擁有不到1%的華潤醫藥控股有限公司股份。然而,內部人士可能通過更復雜的結構間接持有利益。其市值僅爲HK$49億,董事會僅以自己的名義持有HK$180萬價值的股份。許多投資者在較小公司中更希望看到董事會投資更重。您可以點擊這裏查看這些內部人士是否一直在買入或賣出。

General Public Ownership

一般大衆所有權

The general public-- including retail investors -- own 43% stake in the company, and hence can't easily be ignored. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

包括散戶在內的普通公衆擁有該公司43%的股份,因此不能輕易忽視他們。儘管所有權規模相當大,但如果決定與其他大股東不一致,這可能還不足以改變公司政策。

Private Company Ownership

私有公司的所有權

It seems that Private Companies own 37%, of the China Resources Medical Holdings stock. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

中國資源醫療控股股份有限公司的37%股份似乎由私營公司持有。值得進一步深入了解。如果相關方,如內部人員,在這些私營公司中有利害關係,這應在年度報告中披露。私營公司可能也對該公司具有戰略利益。

Next Steps:

下一步:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. For example, we've discovered 2 warning signs for China Resources Medical Holdings that you should be aware of before investing here.

雖然考慮擁有公司股份的不同群體很重要,但還有其他更重要的因素。例如,我們發現了中國資源醫療控股存在2個警告信號,您在投資之前應該了解這些。

If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.

如果您希望了解分析師在未來增長方面的預測,請務必不要錯過這份免費報告。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論